Utama › Kanser Ovari › Michigan › Grand Rapids
Kajian klinikal Kanser Ovari di Grand Rapids, MI
24 kajian untuk Kanser Ovari sedang mencari peserta di lokasi dalam dan sekitar Grand Rapids (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Mengambil pesertaFasa 2/3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Mengambil pesertaFasa 2
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
A Study of PHST001 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- START Center for Cancer Research - Midwest, Grand Rapids
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- South Texas Accelerated Research Therapeutics (START), Grand Rapids
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- BAMF Health, Grand Rapids
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Mengambil pesertaFasa 2
- Site 0228 - Corewell Health Medical Group West, Grand Rapids
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Mengambil pesertaFasa 2
- Research Site, Grand Rapids
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Mengambil pesertaFasa 1
- BAMF Health Inc., Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- START Midwest, Grand Rapids
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Mengambil pesertaKajian pemerhatian
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Mengambil pesertaFasa 1
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- START Midwest, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- START Midwest, Grand Rapids
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Mengambil peserta
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mengambil pesertaFasa 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- START - Midwest, Grand Rapids
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Mengambil pesertaFasa 1/2
- START Midwest, Grand Rapids
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- START Midwest, Grand Rapids
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Mengambil pesertaFasa 3
- Corewell Health, Grand Rapids
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Mengambil pesertaFasa 2
- GSK Investigational Site, Grand Rapids
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
Mengambil pesertaFasa 2/3
- BAMF Health, Grand Rapids
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Mengambil pesertaFasa 1
- START Midwest, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- START Midwest, Grand Rapids
Kajian Kanser Ovari di bandar lain
- Houston, TX89 kajian
- New York City, NY69 kajian
- Boston, MA61 kajian
- Los Angeles, CA50 kajian
- Nashville, TN49 kajian
- Arlington, VA46 kajian
- Philadelphia, PA44 kajian
- Columbus, OH39 kajian
- St. Louis, MO38 kajian
- Chicago, IL36 kajian
- San Antonio, TX31 kajian
- Cleveland, OH30 kajian
Kajian lain di Grand Rapids
- Kanser Paru-paru Bukan Sel Kecil44 kajian
- Kanser Kolorektal40 kajian
- Kanser (semua jenis)28 kajian
- Kanser Payudara26 kajian
- Kanser Metastatik22 kajian
- Kanser Prostat19 kajian
- Kanser Endometrium18 kajian
- Kanser Perut18 kajian
- Kanser Pankreas18 kajian
- Melanoma17 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher15 kajian
- Kanser Payudara Triple-Negatif15 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.